Trials / Unknown
UnknownNCT05148728
Active Surveillance vs in Office Fulguration for Low Grade Bladder Cancer Tumors
Prospective Randomized Trial in Low Grade Bladder Tumors: Active Surveillance vs Endoscopic Fulguration.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Vall Hebron Insitut Recerca · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Biological behabiour of low grade bladder cancer tumors is well known. They have a very high rate of recurrences during their follow up but very low (less than 1%) risk of progression. Until now, the gold standard of any bladder recurrence for this patients is performing an immediate transurethral ressection of the tumor. This surgery has risk of complications and, due to the low risk of these subgroup of tumors, sometimes it becomes an overtreatment for the patients. This is the reason why new conservative or less invasive surgeries are proposed to follow up and treat these patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Endoscopic fulguration | already included. WE will use Storz monopolar device for fulguration |
Timeline
- Start date
- 2021-12-15
- Primary completion
- 2023-12-15
- Completion
- 2024-03-15
- First posted
- 2021-12-08
- Last updated
- 2021-12-08
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05148728. Inclusion in this directory is not an endorsement.